A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-880 in Subjects Who Have Type 1 Diabetes Mellitus With Impaired Hypoglycemic Awareness and Severe Hypoglycemia

drug protocol number
VX20-880-101
drug sponsor
Vertex / CTI
drug study
VX 880
drug trial site
King Abdulaziz Hospital NG (Riyadh)
drug status
Ongoing
drug phase